EUVIMEDEUVIMED entdecken
Open Access

Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease

Jessica L Sheehan, Ariel A Jordan, Kira L Newman, Laura A Johnson, Dala Eloubeidi, Shirley Cohen-Mekelburg, Jeffrey A Berinstein, Renuka Tipirneni, Peter D R Higgins

Digestive Diseases and Sciences · 2025

DOI: 10.1007/s10620-024-08733-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Jessica L Sheehan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, …. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Vaccination, Healthcare Disparities, Social Determinants of Health. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health/Michigan Institute for Clinical and Health Research, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Social determinants of health (SDOH) have a known impact on disparities in vaccination. Despite an increased risk for infection in patients with inflammatory bowel disease (IBD), SDOH and vaccination in this population have not been studied. Using census tract-level data from the Centers for Disease Control's social vulnerability index (SVI), we aimed to understand the relationship between SDOH and adherence to guideline-recommended vaccinations in patients with IBD. METHODS: A single-center retrospective cohort of patients with IBD was used to geocode patient addresses to their individual census tract and corresponding SVI and subthemes (Socioeconomic Status, Household Composition, Minority Status, and Housing/Transportation). We used separate multivariable logistic regressions to examine the relationship between SVI and vaccination against influenza, COVID-19, pneumococcal pneumonia, and herpes zoster. RESULTS: A total of 7,036 patients were included. Rates of vaccination varied across vaccine-types: influenza (57%), COVID-19 (65%), pneumococcal pneumonia (58%), and herpes zoster (11%). High social vulnerability was associated with lower odds of vaccination against influenza (OR 0.47, p < 0.001), COVID-19 (OR 0.54, p < 0.001), pneumonia (OR 0.73, p = 0.012), and herpes zoster (OR 0.39, p < 0.001). Within the SVI subthemes, Socioeconomic Status, Household Composition, and Minority Status were important factors associated with differences in vaccine uptake. CONCLUSION: Higher social vulnerability was associated with lower rates of vaccination across all vaccine types. Identifying these disparities in vaccination for socially vulnerable patients with IBD is the first step to reducing preventable infections and ensuring all patients receive high quality, equitable care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesVaccinationHealthcare DisparitiesSocial Determinants of HealthSocial VulnerabilityHumansMaleFemaleMiddle AgedRetrospective StudiesAdultCOVID-19COVID-19 VaccinesInfluenza VaccinesAged

Stichwörter der Autor:innen

Crohn’s diseaseHealth equityPreventive careUlcerative colitis

Substanzen

COVID-19 VaccinesInfluenza Vaccines

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA. jesheeha@med.umich.edu.
  • Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. jesheeha@med.umich.edu.
  • Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA.
  • Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI, USA.
  • Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.
  • VA Center for Clinical Management Research, VA Ann Arbor Health Care System, Ann Arbor, MI, USA.

Förderung

  • National Institutes of Health/Michigan Institute for Clinical and Health Research
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NIA NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Aging
  • Blue Cross Blue Shield of Michigan
  • Michigan Department of Health & Human Services

Zitieren

APA

Sheehan, J. L., Jordan, A. A., Newman, K. L., Johnson, L. A., Eloubeidi, D., Cohen-Mekelburg, S., Berinstein, J. A., Tipirneni, R., & Higgins, P. D. R. (2025). Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08733-x

Vancouver

Sheehan JL, Jordan AA, Newman KL, Johnson LA, Eloubeidi D, Cohen-Mekelburg S, et al. Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-024-08733-x

BibTeX
@article{Sheehan2025,
  author = {Sheehan, Jessica L and Jordan, Ariel A and Newman, Kira L and Johnson, Laura A and Eloubeidi, Dala and Cohen-Mekelburg, Shirley and Berinstein, Jeffrey A and Tipirneni, Renuka and Higgins, Peter D R},
  title = {Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  doi = {10.1007/s10620-024-08733-x}
}
Kostenlos starten →